Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

ASX:PAR.AX

Overview | Financials
Company Name Paradigm Biopharmaceuticals Limited
Symbol PAR.AX
Currency AUD
Price 0.24
Market Cap 84,087,360
Dividend Yield 0%
52-week-range 0.21 - 0.759
Industry Biotechnology
Sector Healthcare
CEO Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC
Website https://www.paradigmbiopharma.com

An error occurred while fetching data.

About Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company

Related Stocks

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.755 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.064 AUD

Race Oncology Limited logo

Race Oncology Limited

RAC.AX

1.685 AUD

Aroa Biosurgery Limited logo

Aroa Biosurgery Limited

ARX.AX

0.485 AUD

Cogstate Limited logo

Cogstate Limited

CGS.AX

0.965 AUD

Anteris Technologies Ltd logo

Anteris Technologies Ltd

AVR.AX

13.14 AUD

Starpharma Holdings Limited logo

Starpharma Holdings Limited

SPL.AX

0.094 AUD

PYC Therapeutics Limited logo

PYC Therapeutics Limited

PYC.AX

0.145 AUD

AnteoTech Limited logo

AnteoTech Limited

ADO.AX

0.022 AUD

Paragon Care Limited logo

Paragon Care Limited

PGC.AX

0.415 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD